Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan
· Delayed Price · Currency is JPY 1,990.00
+9.00 (0.45%)
May 16, 2025, 3:30 PM JST
Daito Pharmaceutical Revenue
Daito Pharmaceutical had revenue of 12.03B JPY in the quarter ending February 28, 2025, with 13.96% growth. This brings the company's revenue in the last twelve months to 48.84B, up 8.07% year-over-year. In the fiscal year ending May 31, 2024, Daito Pharmaceutical had annual revenue of 46.90B with 3.98% growth.
Revenue (ttm)
48.84B
Revenue Growth
+8.07%
P/S Ratio
0.61
Revenue / Employee
45.65M
Employees
1,070
Market Cap
29.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2024 | 46.90B | 1.79B | 3.98% |
| May 31, 2023 | 45.10B | 1.64B | 3.77% |
| May 31, 2022 | 43.46B | -5.25B | -10.78% |
| May 31, 2021 | 48.71B | 3.72B | 8.27% |
| May 31, 2020 | 44.99B | 3.86B | 9.38% |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
| May 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |